LIGAND PHARMACEUTICALS INC Payments to Acquire Property, Plant, and Equipment in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2010 to Q1 2025.
  • Ligand Pharmaceuticals Inc Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $214K, a 104% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1.82M, a 48.3% decline from 2023.
  • Ligand Pharmaceuticals Inc annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3.52M, a 80.4% decline from 2022.
  • Ligand Pharmaceuticals Inc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $17.9M, a 105% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

LIGAND PHARMACEUTICALS INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $214K +$109K +104% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q1 2024 $105K -$2.31M -95.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q1 2023 $2.41M -$2.46M -50.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $4.88M +$1.47M +43.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $3.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2017 $87K -$151K -63.4% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q1 2016 $238K +$228K +2280% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $10K +$4K +66.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-11-14
Q1 2014 $6K -$31K -83.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $37K +$18K +94.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $19K +$14K +280% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $5K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-11-14

LIGAND PHARMACEUTICALS INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.82M -$1.7M -48.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $3.52M -$14.4M -80.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $17.9M +$9.16M +105% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $8.76M +$4.3M +96.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $4.46M +$1.91M +74.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $2.55M +$1.67M +188% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $887K -$1.27M -58.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $2.16M +$306K +16.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.85M +$1.76M +1889% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $93K +$87K +1450% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $6K -$371K -98.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $377K -$218K -36.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-11-14
2012 $595K +$517K +663% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 $78K +$8K +11.4% Jan 1, 2011 Dec 31, 2011 10-K/A 2014-12-12
2010 $70K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.